(Q45207667)

English

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

scientific article published in March 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

H Miyazaki

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

H Matsuoka

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

J P Cooke

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

M Usui

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

S Ueda

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

S Okuda

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

T Imaizumi

7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

0 references

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1141-1146

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Studies on the catabolism of NG-methylarginine, NG, NG-dimethylarginine and NG, NG-dimethylarginine in the rabbit

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Epidemiology of coronary heart disease: the Framingham study.

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L‐arginine in regenerated endothelial cells

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Nitric oxide synthase: role in the genesis of vascular disease

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Endothelial dysfunction: does it matter? Is it reversible?

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Endothelial dysfunction and atherosclerosis

1 reference

https://www.researchgate.net/publication/13202587_Endogenous_Nitric_Oxide_Synthase_Inhibitor_A_Novel_Marker_of_Atherosclerosis#references

Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis | Request PDF (English)

Identifiers

10.1161/01.CIR.99.9.1141

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45207667&oldid=2070101526"